Skip to Content

Tag: ResMed


Vendors

Sleep study questions adherence requirements 

May 19, 2022HME News Staff

SAN DIEGO – Sleep apnea sufferers can gain health benefits from PAP treatment in as little as two hours per night, according to a study led by ResMed and presented at the American Thoracic Society’s annual international conference.  Researchers found:  The minimum PAP usage threshold for benefit was two to three hours per night (up to 50% lower than the four hours required by CMS and many private insurers to prove adherence);  Benefits begin at two hours of nightly...

Adherence, PAP treatment, ResMed, Sleep Apnea


Read Full Articlered right arrow icon

News

In brief: Invacare layoffs, Philips recall, ResMed exec

May 6, 2022HME News Staff

ELYRIA, Ohio – Invacare is streamlining its operations in the United States, primarily related to headcount reductions, to improve its cost structure, according to a May 4 filing with the U.S. Securities and Exchange Commission.  As a result, the company anticipates annual pre-tax savings of about $2.8 million, with about $1.9 million to be realized in 2022. It will incur restructuring charges of $800,000 and expects to make cash payments in the same amount, primarily related to...

Caire, Insulet, Invacare, Motion, Philips Recall, Quality Biomedical, ResMed, Rhythm Healthcare


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed: ‘This is a humanitarian emergency’

April 29, 2022Liz Beaulieu, Editor

SAN DIEGO – ResMed has “five lines of work” to pump more of its CPAP devices into the market amid ongoing supply chain challenges, including a new AirSense 10 card-to-cloud device, says CEO Mick Farrell.  The company has launched the device – which is “basically an AirSense 10 without the cell chip in it,” says Jim Hollingshead, president, Sleep and Respiratory Care Business – only in select markets, but it’s in the process of adding markets.  “Look,...

AirSense, CPAP recall, Mick Farrell, ResMed


Read Full Articlered right arrow icon

Vendors

ResMed: ‘Our third-quarter results reflect strong performance’

April 28, 2022HME News Staff

SAN DIEGO – ResMed reported revenue increased 12% to $864.5 million in its third quarter fiscal year 2022. The company reported revenue, excluding software-as-a-service, increased 18% in the United States, Canada and Latin America, primarily due to a recall by one of its competitors and a recovery of core sleep patient flow that has been impacted by the COVID-19 pandemic. “Our third-quarter results reflect strong performance across our business, resulting in double-digit top-line...

CPAP Devices, CPAP recall, Financial Results, ResMed, Sleep Therapy


Read Full Articlered right arrow icon

News

Report: Recall causes shifts in sleep therapy market

April 5, 2022HME News Staff

NEW YORK – HME providers expect to shift an average of 58.4% of their Philips Respironics flow generator purchases and an average of 30.2% of their mask purchases to other companies due to the recall, according to the first quarter HME Sleep and Oxygen Survey from Needham.  That’s up from the 56% and 23.1%, respectively, reported in the third quarter survey.  “ResMed should gain market share over the (next 12 months),” the survey states. “Respondents...

CPAP recall, Needham survey, Philips Respironics, ResMed


Read Full Articlered right arrow icon

Vendors

ResMed survey outlines what’s keeping Americans up at night 

March 15, 2022HME News Staff

SAN DIEGO – About 52% of Americans reported snoring or being told they snore, but only 33% are concerned about the associated health implications, according to ResMed’s 2022 Global Sleep Surveys.  “Sleep quality can be impacted by lifestyle changes and poor habits, but many people are struggling with undiagnosed conditions that may be the root cause,” said Carlos M. Nunez, M.D., ResMed’s chief medical officer. “Sleep apnea is a serious health concern, but...

CPAP Device, Obstructive Sleep Apnea, ResMed, sleep survey


Read Full Articlered right arrow icon

ResMed names new CTO

Vendors

ResMed names new CTO

February 1, 2022HME News Staff

SAN DIEGO – ResMed has appointed Urvashi Tyagi as CTO to lead the company’s Digital Health Technology team. She is charged with driving the innovation and adoption of ResMed’s cloud-based digital health platforms, as well as making investments in emerging technologies like artificial intelligence and machine learning. “Urvashi brings world-class technology and engineering know-how, combined with senior leadership experience from other top fintech and consumer tech...

Artificial intelligence (AI), CTO, digital health technology, Machine learning, ResMed


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed benefits from up to $55M in incremental revenue

January 28, 2022Liz Beaulieu, Editor

SAN DIEGO – Demand for CPAP devices is so high right now that, despite current supply chain constraints, ResMed was able to increase sales by double digits in the United States, Canada and Latin America for the second quarter in a row.  The company posted a 19% increase in sales for CPAP devices in the second quarter of its fiscal year 2022, on the back of a 40% increase in the first quarter, largely as a result of a competitor’s recall.  “In relation to the impact...

CPAP, Mick Farrell, ResMed


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed posts double-digit increases

January 28, 2022HME News Staff

SAN DIEGO – ResMed reported revenue of $894.9 million for the second quarter of fiscal year 2022, a 12% increase compared to the same period the prior year.  It reported net income of $201.8 million, also a 12% increase.  “Our second-quarter results reflect continued strong performance across our business resulting in double-digit top-line revenue growth, driven by ongoing high demand for our sleep and respiratory care products, and solid growth in our software-as-a-service...

Mick Farrell, ResMed


Read Full Articlered right arrow icon

Also Noted

ResMed invests in Scottish tech start-up

December 2, 2021HME News Staff

SAN DIEGO – ResMed has made a minority investment in Lenus Health, an Edinburgh, Scotland-based health-tech startup that specializes in improving outcomes and lowering costs for people with chronic obstructive pulmonary disease, according to the Scottish Business Times. “Lenus Health’s achievements underscore the power of digital health to improve people’s lives, delivering care closer to home while also significantly reducing health care costs for whole systems,” said...

COPD, Lenus Health, ResMed


Read Full Articlered right arrow icon